Sales of Sovaldi, New Gilead Hepatitis C Drug, Soar to $10.3 Billion
Wednesday, February 4, 2015 - 01:10
in Mathematics & Economics
Global sales of Sovaldi brought it close to being the best-selling drug in the world in only its first year on the market.